Nkarta (NKTX) Asset Utilization Ratio (2020)

Nkarta (NKTX) posted quarterly Asset Utilization Ratio of 0.0 for Q4 2020, down 111.49% quarter-over-quarter from 0.0 in Q3 2020.

Nkarta (NKTX) Asset Utilization Ratio (2020) Analysis & Trends

Nkarta's Asset Utilization Ratio history runs 1 years deep, the most recent figure standing at 0.0 for Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	0.47
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	0.38
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	0.20
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	0.69
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	0.90
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	0.13
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	0.54
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	0.13
10	Nkarta	201.14 Mn	201.14 Mn	-	-

Download Data

Date	Value
Dec 31, 2020	0.00
Sep 30, 2020	0.00